Triple action eye drops for allergy symptoms
Part of Eyes & vision, Immune system & allergy clinical trials.
This trial tests an eye drop called Daydrop Triple Action to see if it helps with eye itching and redness caused by allergies. It might be a good option if you have allergic conjunctivitis and have not used other allergy eye medications recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have an active episode of allergic conjunctivitis (eye allergy) confirmed by a specialist with a slit-lamp exam.
- You have at least moderate itching or redness in your eyes (score of 2 or more).
- You can use the eye drops yourself and understand the study information.
- You have not used certain allergy or anti-inflammatory eye drops (except artificial tears) or allergy/corticosteroid pills within the last 7 days.
- You do not have other eye conditions (like glaucoma, severe dry eye, or eye infection) or had eye surgery in the last 3 months (or laser eye surgery in the last 6 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if Kelulut honey eye drops can help people with both allergic conjunctivitis (eye allergies) and dry eye symptoms. If you have been diagnosed with eye allergies and still have bothersome symptoms despite treatment, this trial may offer a natural option to explore.
This trial tests a new eye drop to reduce itching and other symptoms of allergic conjunctivitis, a condition where the eyes become red, itchy, and uncomfortable due to allergies. It may help people who have not found relief with current treatments.
This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.
This trial tests an investigational eye drop called TL-925 for people with seasonal allergic conjunctivitis (eye allergies triggered by pollen, grass, etc.). It aims to see if TL-925 can relieve symptoms like redness and itching.
This trial tests a new eye drop (0.4% solution) to see if it's safe and effective for people with dry eye. It's for both contact lens wearers and non-wearers who have dry eye symptoms, and aims to find a better way to relieve discomfort.
This study tests an experimental eye drop for people with dry eye disease. It aims to see if the drops can reduce symptoms and signs of dry eye.
Hear when a new Allergic Conjunctivitis of Both Eyes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.